Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Clark

Showing results (161-170 of 305) with videos related to

Pageof 31
Sort By:
Materials Today. Bio|September 22, 2023
In situ forming biomaterials as muscle void fillers for the provisional treatment of volumetric muscle loss injuriesAndrew Clark, Jonathan Kulwatno, Sergey S Kanovka, et al.
HIV Medicine|November 13, 2022
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co-administrationNneka Nwokolo, Elana Post, A Savannah Mageau, et al.
Plos One|July 2, 2011
Comparative economic evaluation of Haemophilus influenzae type b vaccination in Belarus and UzbekistanUlla K Griffiths, Andrew Clark, Veronika Shimanovich, et al.
Antiviral Research|July 6, 2024
Characterization of clinical envelopes with lack of sensitivity to the HIV-1 inhibitors temsavir and ibalizumabMargaret Gartland, Eugene Stewart, Nannan Zhou, et al.
Antiviral Research|July 3, 2024
The sensitivity of HIV-1 gp120 polymorphs to inhibition by temsavir correlates to temsavir binding on-rateDavid Wensel, Margaret Gartland, Jagadish Beloor, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 19, 2025
In vitro-in vivo relationship and microstructural insights into long-acting levonorgestrel intrauterine systemsSuraj Fanse, Andrew Clark, Quanying Bao, et al.
Vaccine|June 20, 2013
TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccinationAndrew Clark, Barbara Jauregui, Ulla Griffiths, et al.
International Journal of Toxicology|August 14, 2020
Novel Toxicology Program to Support the Development of Inhaled VentaProstJeffrey Tepper, Juergen Pfeiffer, Kim Bujold, et al.
Dementia (London, England)|December 27, 2019
'<i>Our voice started off as a whisper and now it is a great big roar</i>': The Salford Dementia Associate Panel as a model of involvement in research activitiesRon Bowker, Lesley Calvert, Frances Allcroft, et al.
Journal of Global Health|November 13, 2025
Cost-effectiveness of introducing a maternal vaccine or long-acting monoclonal antibody to prevent infant respiratory syncytial virus disease in NepalNeele Rave, Arun K Sharma, Ram H Chapagain, et al.
Pageof 31

Showing results (161-170 of 305) with videos related to

Sort By:
Pageof 31
Materials Today. Bio|September 22, 2023
In situ forming biomaterials as muscle void fillers for the provisional treatment of volumetric muscle loss injuriesAndrew Clark, Jonathan Kulwatno, Sergey S Kanovka, et al.
HIV Medicine|November 13, 2022
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co-administrationNneka Nwokolo, Elana Post, A Savannah Mageau, et al.
Plos One|July 2, 2011
Comparative economic evaluation of Haemophilus influenzae type b vaccination in Belarus and UzbekistanUlla K Griffiths, Andrew Clark, Veronika Shimanovich, et al.
Antiviral Research|July 6, 2024
Characterization of clinical envelopes with lack of sensitivity to the HIV-1 inhibitors temsavir and ibalizumabMargaret Gartland, Eugene Stewart, Nannan Zhou, et al.
Antiviral Research|July 3, 2024
The sensitivity of HIV-1 gp120 polymorphs to inhibition by temsavir correlates to temsavir binding on-rateDavid Wensel, Margaret Gartland, Jagadish Beloor, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 19, 2025
In vitro-in vivo relationship and microstructural insights into long-acting levonorgestrel intrauterine systemsSuraj Fanse, Andrew Clark, Quanying Bao, et al.
Vaccine|June 20, 2013
TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccinationAndrew Clark, Barbara Jauregui, Ulla Griffiths, et al.
International Journal of Toxicology|August 14, 2020
Novel Toxicology Program to Support the Development of Inhaled VentaProstJeffrey Tepper, Juergen Pfeiffer, Kim Bujold, et al.
Dementia (London, England)|December 27, 2019
'<i>Our voice started off as a whisper and now it is a great big roar</i>': The Salford Dementia Associate Panel as a model of involvement in research activitiesRon Bowker, Lesley Calvert, Frances Allcroft, et al.
Journal of Global Health|November 13, 2025
Cost-effectiveness of introducing a maternal vaccine or long-acting monoclonal antibody to prevent infant respiratory syncytial virus disease in NepalNeele Rave, Arun K Sharma, Ram H Chapagain, et al.
Pageof 31